Patents by Inventor Vivien Chan

Vivien Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100196377
    Abstract: The invention provides, inter alia, methods for treating cancer, compositions for treating cancer, and methods and compositions for diagnosing and/or detecting cancer. In particular, the present invention provides compositions and methods for treating, diagnosing and detecting cancers associated with LIV-1 overexpression.
    Type: Application
    Filed: April 12, 2007
    Publication date: August 5, 2010
    Inventors: Mary J. Jantapour, Guoying Yu, Robert To, Vivien Chan, Deborah Zimmerman
  • Patent number: 7279554
    Abstract: The invention provides polynucleotides encoding Notch receptor ligands, encoded polypeptides, and antibodies specific to the polypeptides. Also provided are methods and compositions for enhancing or inhibiting angiogenesis as well as modulating immune responses.
    Type: Grant
    Filed: August 20, 2003
    Date of Patent: October 9, 2007
    Assignee: Chiron Corporation
    Inventors: Vivien Chan, Michael Rohan, Lewis T. Williams
  • Publication number: 20070010469
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: September 22, 2004
    Publication date: January 11, 2007
    Inventors: Vivien Chan, Jaime Escobedo, Pablo Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia Kennedy, George Lamson, Edward Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Publication number: 20050130926
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: October 28, 2004
    Publication date: June 16, 2005
    Inventors: Christoph Reinhard, Anne Jefferson, Vivien Chan, Joerg Kaufmann, Hong Xin, Giulia Kennedy, Greg Harrowe, Hamiduddin Khoja, Venkatakrishna Shyamala
  • Publication number: 20050063974
    Abstract: The present invention provides methods for identification of cancerous cells by detection of expression levels of TTK, as well as diagnostic, prognostic and therapeutic methods that take advantage of the differential expression of these genes in mammalian cancer. Such methods can be useful in determining the ability of a subject to respond to a particular therapy, e.g., as the basis of rational therapy. In addition, the invention provides assays for identifying pharmaceuticals that modulate activity of these genes in cancers in which these genes are involved, as well as methods of inhibiting tumor growth by inhibiting activity of TTK.
    Type: Application
    Filed: September 27, 2004
    Publication date: March 24, 2005
    Inventors: Christoph Reinhard, Anne Jefferson, Vivien Chan
  • Publication number: 20050058627
    Abstract: The present invention provides methods for identification of cancerous cells by detection of expression levels of TTK, as well as diagnostic, prognostic and therapeutic methods that take advantage of the differential expression of these genes in mammalian cancer. Such methods can be useful in determining the ability of a subject to respond to a particular therapy, e.g., as the basis of rational therapy. In addition, the invention provides assays for identifying pharmaceuticals that modulate activity of these genes in cancers in which these genes are involved, as well as methods of inhibiting tumor growth by inhibiting activity of TTK.
    Type: Application
    Filed: September 27, 2004
    Publication date: March 17, 2005
    Inventors: Christoph Reinhard, Anne Jefferson, Vivien Chan
  • Publication number: 20050059630
    Abstract: The present invention provides methods for identification of cancerous cells by detection of expression levels of TTK, as well as diagnostic, prognostic and therapeutic methods that take advantage of the differential expression of these genes in mammalian cancer. Such methods can be useful in determining the ability of a subject to respond to a particular therapy, e.g., as the basis of rational therapy. In addition, the invention provides assays for identifying pharmaceuticals that modulate activity of these genes in cancers in which these genes are involved, as well as methods of inhibiting tumor growth by inhibiting activity of TTK.
    Type: Application
    Filed: September 27, 2004
    Publication date: March 17, 2005
    Inventors: Christoph Reinhard, Anne Jefferson, Vivien Chan
  • Publication number: 20040137569
    Abstract: The invention provides polynucleotides encoding Notch receptor ligands, encoded polypeptides, and antibodies specific to the polypeptides. Also provided are methods and compositions for enhancing or inhibiting angiogenesis as well as modulating immune responses.
    Type: Application
    Filed: August 20, 2003
    Publication date: July 15, 2004
    Applicant: Chiron Corporation
    Inventors: Vivien Chan, Michael Rohan, Lewis T. Williams
  • Patent number: 6703221
    Abstract: The invention provides polynucleotides encoding Notch receptor ligands, encoded polypeptides, and antibodies specific to the polypeptides. Also provided are methods and compositions for enhancing or inhibiting angiogenesis as well as modulating immune responses.
    Type: Grant
    Filed: August 17, 2000
    Date of Patent: March 9, 2004
    Assignee: Chiron Corporation
    Inventors: Vivien Chan, Michael Rohan, Lewis T. Williams